Merck gets USFDA Breakthrough Therapy Designation for Raludotatug deruxtecan for Platinum-Resistant Ovarian Cancer
- 17 September 2025
- 18 hours ago
One Exercise Session Could Slow Breast Cancer Growth Significantly: Study Shows
- 16 September 2025
- 1 day ago
FDA Approves INLEXZO™ for BCG-Unresponsive Bladder Cancer
- 15 September 2025
- 2 days ago
Homi Bhabha Cancer Hospital gets permission to begin 3 new super-speciality courses
- 14 September 2025
- 3 days ago
Millions of men could benefit from faster scan to diagnose prostate cancer: JAMA
- 13 September 2025
- 4 days ago
India Sees Sharp Rise in Deaths from Lifestyle Diseases: Global Study Finds
- 13 September 2025
- 4 days ago
SOX2: a key player in prostate cancer progression and treatment resistance: Study
- 11 September 2025
- 6 days ago
Revolutionary Cancer Treatment Shows Promise
- 11 September 2025
- 6 days ago
Penile Implant Satisfaction Drops in Prostate Cancer Patients on Hormonal Treatment, reveals study
- 11 September 2025
- 6 days ago
Recent News
HC asks KNRUHS to consider MBBS aspirant's plea fo...
- 17 September, 2025
Hospital associations seek restoration of cashless...
- 17 September, 2025
Assam NHM Rural doctors announce strike on Septemb...
- 17 September, 2025
Gorakhpur NEET aspirant killed in clash between vi...
- 17 September, 2025
MCC NEET 2025 Round 2 Counselling Provisional Resu...
- 17 September, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.